对改善帕金森病中吞和咳功能的行为疗法的系统审查
Shakeela Saleem1,2, Anna Miles1, Jacqueline Allen3
1School of Psychology, The University of Auckland, Auckland, New Zealand.
International journal of speech-language pathology
|August 3, 2023
概括
在帕金森病 (PD) 中,行为疗法有望改善吞,呼吸和咳功能. 需要进一步的研究来确认严重PD病例的长期影响和益处.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 语音语言病理学 语音语言病理学
背景情况:
- 帕金森病 (PD) 显著影响运动功能,包括吞,呼吸和咳.
- 缺食症,呼吸功能障碍和咳反射障碍是PD的常见和严重并发症.
- 治疗干预对于管理这些功能缺陷和改善生活质量至关重要.
研究的目的:
- 系统地审查治疗干预措施的疗效,以改善帕金森病患者的吞,呼吸和咳功能.
- 为了探索各种疗法后的吞,呼吸和咳功能的跨系统结果.
- 评估这些干预措施的证据质量,使用Cochrane的偏见风险工具.
主要方法:
- 在六个数据库中进行了PRISMA系统搜索.
- 研究包括对针对吞,呼吸或咳结果的行为疗法的评估前和后数据.
- 排除标准包括医疗/外科治疗和单次会议设计. 使用Cochrane工具评估了偏差风险.
主要成果:
- 分析了36篇文章,分为吞 (5),电磁刺激 (4),呼吸负荷 (20) 和语音负荷 (7) 疗法.
- 高质量的证据支持一些行为疗法提高特定的吞效率,呼吸系统措施和咳功能.
- 只有11项研究具有低偏差风险;其他研究在报告失明,缺失数据,坚持和组分配方面存在局限性.
结论:
- 行为疗法提供了多样化的方法,有可能在帕金森病患者的吞,呼吸和咳功能方面带来广泛的跨系统益处.
- 未来的试验应该集中在长期随访,更大的患者队伍和更晚期疾病阶段的个体上.
- 这些发现强调了需要严格的研究设计来确认这些干预措施的有效性.
相关概念视频
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...